Uber deal will have 'zero issues' despite watchdog reservations, says Grab CEO

Anti-competition watchdogs in Malaysia and the Philippines are keeping a close eye on the deal that will see Grab sweep up Uber in South East Asia
Grab chief executive Anthony Tan is confident that the ride-hailing firm’s deal with Uber will be completed with “zero issues”.
Mr Tan said on Tuesday that he believes regulators will not oppose Grab's plan to buy Uber’s ride-hailing and food delivery business in South East Asia, despite Malaysian authorities warning that they would monitor Grab for potential “anti-competitive” behaviour in the region.
The Philippines competition watchdog has also voiced its reservations, calling the tie-up a “virtual duopoly”.
Read more Why we might need new cities after the Uber self-driving car death Speaking to the BBC, Mr Tan said: “The number one thing that any regulator is concerned about is how do we make sure that we as, a leader do not set a bad example, do not take advantage.
“So we are out there, we are very visible, to say 'Loo..

Feature: The Case of Hong Kong’s Missing Booksellers

The Case of Hong Kong’s Missing Booksellers Lam Wing-kee knew he was in trouble. In his two decades as owner and manager of Hong Kong’s Causeway Bay Books, Lam had honed a carefully nonchalant routine when caught smuggling books into mainland China: apologize, claim ignorance, offer a cigarette to the officers, crack a joke. For most of his career, the routine was foolproof.
Thin and wiry, with an unruly pouf of side-swept gray hair and a wisp of mustache, Lam was carrying a wide mix of books that day: breathless political thrillers, bodice-rippers and a handful of dry historical tomes. The works had only two things in common: Readers hungered for them, and each had been designated contraband by the Communist Party’s Central Leading Group for Propaganda and Ideology. For decades, Lam’s bookstore had thrived despite the ban — or maybe because of it. Operating just 20 miles from the mainland city of Shenzhen, in a tiny storefront sandwiched between a pharmacy and an upscale lingerie stor..

China Finds California Wine Pairs Well With a Trade War

China Finds California Wine Pairs Well With a Trade War
Retaliatory tariffs are a blow to exporters increasingly catering to young, newly wealthy Chinese looking for bottles with cachet.

Cabernet isn’t the most obvious pawn in a trade war between the United States and China. Airplanes and their parts are the leading American export to China. Soybeans and wheat grow in Trump country.
But China’s selection of wine as a target of retaliatory tariffs did not surprise Michael Honig, a winemaker in the Napa Valley, where the tariff would hit hardest.
“The reason the government realizes they should penalize us is, we are branded,” said Mr. Honig, the president of Honig Vineyard and Winery. “It’s hard to go after a wheat grower, because who is a wheat grower? It’s a commodity. We are not a commodity.”
The news was an unwelcome turn of events for Mr. Honig and many California winemakers, who have spent years trying to carve out a place in the hearts of wealthy Chinese consumers. That hard wor..

On Medicine: Can Doctors Choose Between Saving Lives and Saving a Fortune?

Supported by Magazine Can Doctors Choose Between Saving Lives and Saving a Fortune? Photo Credit Photo illustration by Cristiana Couceiro. Syringe: Peter Dazeley/Getty Images. To understand something about the spiraling cost of health care in the United States, we might begin with a typical conundrum: Imagine a 60-something man — a nonsmoker, overweight, with diabetes — who has just survived a heart attack. Perhaps he had an angioplasty, with the placement of a stent, to open his arteries. The doctor’s job is to keep the vessels open. She has two choices of medicines to reduce the risk for a second heart attack. There’s Plavix, a tried-and-tested blood thinner, that prevents clot formation; the generic version of the drug costs as little as 25 cents a pill. And there’s Brilinta, a newer medicine that is also effective in clot prevention; it costs about $6.50 a pill — 25 times as much.
Brilinta is admittedly more effective than Plavix — by all of 2 percentage points. In a yearlong ..